182 related articles for article (PubMed ID: 18522142)
1. Increased mortality associated with elevated carcinoembryonic antigen in insurance applicants.
Stout RL; Fulks M; Dolan VF; Magee ME; Suarez L
J Insur Med; 2007; 39(4):251-8. PubMed ID: 18522142
[TBL] [Abstract][Full Text] [Related]
2. Mortality associated with bilirubin levels in insurance applicants.
Fulks M; Stout RL; Dolan VF
J Insur Med; 2009; 41(1):49-53. PubMed ID: 19518005
[TBL] [Abstract][Full Text] [Related]
3. Association of Carcinoembryonic Antigen with Mortality in an Insurance Applicant Population.
Rigatti SJ; Stout R
J Insur Med; 2019; 48(1):24-35. PubMed ID: 31747325
[No Abstract] [Full Text] [Related]
4. Using liver enzymes as screening tests to predict mortality risk.
Fulks M; Stout RL; Dolan VF
J Insur Med; 2008; 40(3-4):191-203. PubMed ID: 19317327
[TBL] [Abstract][Full Text] [Related]
5. Trends in mortality of insurance applicants with HIV infection.
Stout RL; Fulks M; Dolan VF
J Insur Med; 2012; 43(2):67-75. PubMed ID: 22876410
[TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial.
Grossmann I; de Bock GH; Meershoek-Klein Kranenbarg WM; van de Velde CJ; Wiggers T
Eur J Surg Oncol; 2007 Mar; 33(2):183-7. PubMed ID: 17174516
[TBL] [Abstract][Full Text] [Related]
7. Scoring life insurance applicants' laboratory results, blood pressure and build to predict all-cause mortality risk.
Fulks M; Stout RL; Dolan VF
J Insur Med; 2012; 43(3):169-77. PubMed ID: 23451618
[TBL] [Abstract][Full Text] [Related]
8. Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study.
Bjerner J; Høgetveit A; Wold Akselberg K; Vangsnes K; Paus E; Bjøro T; Børmer OP; Nustad K
Scand J Clin Lab Invest; 2008; 68(8):703-13. PubMed ID: 18609108
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of preoperative carcinoembryonic antigen level for clinical stage I non-small cell lung cancer: can preoperative carcinoembryonic antigen level predict pathological stage?
Kawachi R; Nakazato Y; Takei H; Koshi-ishi Y; Goya T
Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):199-202. PubMed ID: 19457896
[TBL] [Abstract][Full Text] [Related]
10. Five years' follow-up of patients with elevated carcinoembryonic antigen (CEA) and alcoholic liver disease, with special reference to mortality rate and development of malignancy.
Bell H; Orjasaeter H
Hepatogastroenterology; 1983 Aug; 30(4):140-2. PubMed ID: 6629305
[TBL] [Abstract][Full Text] [Related]
11. Trends in mortality differentials and life expectancy for male social security-covered workers, by socioeconomic status.
Waldron H
Soc Secur Bull; 2007; 67(3):1-28. PubMed ID: 18605216
[TBL] [Abstract][Full Text] [Related]
12. A study of factors influencing plasma CEA levels in an unselected population.
Herbeth B; Bagrel A
Oncodev Biol Med; 1980; 1(4-5):191-8. PubMed ID: 7279704
[TBL] [Abstract][Full Text] [Related]
13. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases.
Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR
Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469
[TBL] [Abstract][Full Text] [Related]
14. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery.
Park JW; Lim SB; Kim DY; Jung KH; Hong YS; Chang HJ; Choi HS; Jeong SY
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):810-7. PubMed ID: 19101093
[TBL] [Abstract][Full Text] [Related]
15. Perioperative carcinoembryonic antigen measurements to predict curability after liver resection for colorectal metastases: a prospective study.
Oussoultzoglou E; Rosso E; Fuchshuber P; Stefanescu V; Diop B; Giraudo G; Pessaux P; Bachellier P; Jaeck D
Arch Surg; 2008 Dec; 143(12):1150-8; discussion 1158-9. PubMed ID: 19075165
[TBL] [Abstract][Full Text] [Related]
16. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
17. Urine protein/creatinine ratio as a mortality risk predictor in non-diabetics with normal renal function.
Fulks M; Stout RL; Dolan VF
J Insur Med; 2012; 43(2):76-83. PubMed ID: 22876411
[TBL] [Abstract][Full Text] [Related]
18. Serum globulin predicts all-cause mortality for life insurance applicants.
Fulks M; Stout RL; Dolan VF
J Insur Med; 2014; 44(2):93-8. PubMed ID: 25816467
[TBL] [Abstract][Full Text] [Related]
19. Utility of serum preoperative carcinoemberyonic antigen in colorectal cancer patients.
El-Awady S; Lithy R; Morshed M; Khafagy W; Abd Monem H; Waleed O; Badr S; Fekry A; El Nakeeb A; Ghazy H; El Yamany M; Metwally T; El-Arman M; Farid M
Hepatogastroenterology; 2009; 56(90):361-6. PubMed ID: 19579599
[TBL] [Abstract][Full Text] [Related]
20. Elevated carcinoembryonic antigen (CEA) levels in a patient with no malignancy.
Shapiro M; Scapa E
Hepatogastroenterology; 2000; 47(31):163-4. PubMed ID: 10690602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
